This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists
Pulmonary Arterial Hypertension: Screening, Diagnosis, and Optimizing Management
Leading the Charge on Obesity Management: The Endocrinologist’s Role in Empowering Community Providers to Join the Fight
Analyzing Key Data from LAG-3 Combinations in the Treatment of Metastatic Melanoma
Navigating Treatment-Related Adverse Effects in LAG-3 Combination ICI Therapy for Metastatic Melanoma
Future Directions: Targeting LAG-3 in Melanoma Treatment
Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage III/IV Melanoma
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints
Optimizing Therapeutic Selection for a Patient With Newly Diagnosed BRAF V600e-Mutated Metastatic Melanoma
First-Line Treatment of Metastatic Melanoma After Adjuvant Anti-PD-1
Patient Case: Tailoring First-Line Treatment for a Patient With Metastatic Melanoma and Impaired Performance Status
How Can a Multidisciplinary Team Optimize Management of G/GEJ Cancer–Related Symptom Burden?
Integrating Clinical Insights: Key G/GEJ Cancer Data Analyzed from the San Diego Oncology Conference
Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for First-Line G/GEJ Cancer Therapy
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video